|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.38 CNY | -3.45% |
|
+9.23% | +2.06% |
| 07-14 | Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-16 | Tasly Subsidiary Gets China Approval for Hypertension Drug | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.45% | +9.23% | +9.08% | +7.93% | +2.06% | -4.89% | +4.84% | +11.61% | -45.21% | 3.39B | |
| -1.32% | +5.33% | +5.13% | -7.00% | -9.41% | -8.54% | -5.55% | -31.22% | +2.55% | 13.54B | |
| -3.30% | +9.97% | +8.77% | -6.09% | -19.28% | -27.26% | -50.84% | -29.34% | -20.10% | 5.27B | |
| -2.47% | +7.14% | +5.94% | -7.22% | +2.14% | +1.11% | -5.02% | +42.41% | -14.38% | 4.72B | |
| -5.06% | +6.38% | +10.37% | -1.14% | -3.34% | +8.84% | -33.36% | -12.42% | +31.70% | 4.07B | |
| -2.65% | +2.32% | +0.48% | -6.86% | -16.90% | +6.01% | -12.59% | +47.45% | +106.82% | 3.75B | |
| 0.00% | +9.56% | 0.00% | +5.42% | -0.19% | -4.89% | -4.23% | +60.85% | -7.99% | 3.57B | |
| -3.77% | +0.45% | +1.10% | -6.77% | -0.51% | -13.51% | -23.54% | -28.36% | - | 2.42B | |
| -2.82% | +3.13% | +9.54% | +6.26% | +8.16% | -2.01% | +47.66% | +111.12% | +90.64% | 1.86B | |
| -4.32% | +4.89% | +6.16% | -9.79% | -11.16% | -8.65% | -11.27% | -28.14% | -28.63% | 1.76B | |
| -2.95% | +3.88% | +4.14% | -8.55% | -4.04% | -6.14% | -25.17% | -5.73% | -38.51% | 1.6B | |
| -4.37% | +3.47% | +8.97% | -7.34% | -6.82% | -19.21% | -37.40% | -23.90% | -46.35% | 1.45B | |
| -5.90% | +3.05% | +6.37% | -10.92% | -14.17% | -25.71% | +17.15% | +60.72% | +44.03% | 1.42B | |
| -6.52% | +10.66% | +14.89% | -5.05% | +3.44% | -24.18% | -30.48% | -7.57% | -63.66% | 1.13B | |
| -2.69% | +2.13% | +9.30% | -5.17% | -4.96% | -10.73% | -20.85% | +0.83% | -31.56% | 1.16B | |
| -1.23% | +8.86% | +12.26% | +11.53% | -7.65% | -15.80% | -39.30% | -15.65% | -39.38% | 1.18B | |
| -4.87% | +5.69% | +10.26% | -13.31% | -16.35% | -26.92% | -53.36% | -66.32% | -31.23% | 1.09B | |
| +1.03% | +1.03% | +4.26% | +5.95% | +8.89% | +39.50% | +59.35% | -56.83% | +1,251.72% | 1.05B | |
| -4.26% | -0.22% | +3.69% | -12.96% | +3.45% | -16.82% | -46.49% | -36.62% | -76.86% | 906M | |
| -5.87% | -29.99% | -29.30% | -37.85% | -29.45% | -21.61% | +24.90% | -18.63% | -57.11% | 626M | |
| Average | -3.34% | +0.81% | +5.07% | -5.45% | -5.80% | -9.07% | -12.28% | -1.29% | +54.03% | 2.8B | |
| Weighted average by Cap. | -2.76% | +2.33% | +5.74% | -4.44% | -6.55% | -7.69% | -13.12% | -1.15% | +23.81% |
- Stock Market
- Stocks
- 600535 Stock
- Sector Tasly Pharmaceutical Group Co., Ltd
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
